Abstract
Clinical Bottom Line:
There is limited, weak evidence that oclacitinib is a suitable alternative to glucocorticoids for managing pruritus in cats. However, there is no good quality
published evidence on the optimal dose of oclacitinib for cats or the risk of adverse effects for administration beyond 28 days.
• Given the evidence available, it is not possible to recommend oclacitinib as an
alternative to oral glucocorticoids for the management of allergic skin disease in
cats.
There is limited, weak evidence that oclacitinib is a suitable alternative to glucocorticoids for managing pruritus in cats. However, there is no good quality
published evidence on the optimal dose of oclacitinib for cats or the risk of adverse effects for administration beyond 28 days.
• Given the evidence available, it is not possible to recommend oclacitinib as an
alternative to oral glucocorticoids for the management of allergic skin disease in
cats.
| Original language | English |
|---|---|
| Pages (from-to) | 304-306 |
| Number of pages | 3 |
| Journal | Veterinary Record |
| Volume | 191 |
| Issue number | 7 |
| DOIs | |
| Publication status | Published - 8 Oct 2022 |